3 Lesser-Known Quantum Plays the Market May Be Overlooking Right Now

D-Wave Quantum shares have fallen 33% year to date as investors reacted negatively to a concerning earnings report. The decline highlights widening performance divergence among quantum-computing companies as the industry matures.

Analysis

QBTS’s weakness is more likely to raise its cost of capital than impair the quantum-computing category. In a pre-scale business, equity-funded R&D and commercial deployment are the operating model; a lower share price increases dilution per dollar raised and can constrain the ability to fund hardware upgrades, customer pilots, and sales capacity. That creates a reflexive competitive advantage for better-capitalized alternatives—IONQ and RGTI within public pure plays, and IBM, GOOG, and MSFT among incumbents able to subsidize quantum development from existing cash flows.

The key near-term question is whether the selloff becomes a technical reset or a fundamental financing event. Over the next 1-3 months, watch cash burn relative to cash on hand, backlog conversion into recognized revenue, gross-margin trajectory, and any revision to commercialization milestones; these matter more than quantum-technology claims. A financing announcement, reduced bookings outlook, or failure to demonstrate growing paid customer usage would likely extend multiple compression, while a material government/enterprise contract or improved cash runway would invalidate a bearish tactical view.

Consensus may be treating all listed quantum names as interchangeable high-beta exposure. D-Wave’s annealing-oriented approach addresses optimization workloads, but that differentiation only supports valuation if customers convert pilots into recurring revenue; absent evidence of that conversion, it should trade more like a capital-intensive early-stage hardware company than a scarce AI-adjacent software asset. The structural opportunity is therefore dispersion, not a broad quantum-sector short: firms with stronger balance sheets can gain partner and talent share if weaker peers retrench over the next 6-18 months.

Key Decisions for Investors

• Do not chase the initial QBTS decline without current cash-runway, short-interest, and borrow-cost data; maintain a downside watch rather than a new outright short until the next liquidity or bookings disclosure.
• If QBTS rallies 15-20% without a corresponding improvement in cash runway or contracted-revenue metrics, consider a 1-3 month tactical short or put spread; cover on a disclosed financing that extends runway beyond 18 months or on a material enterprise contract with recurring-revenue terms.
• Express expected dispersion via a modest long IONQ / short QBTS pair over 3-6 months only after normalizing for beta and market capitalization; the thesis is relative financing flexibility, not a directional call on quantum adoption. Exit if IONQ’s own cash burn accelerates or QBTS demonstrates sustained backlog conversion.
• For lower-volatility exposure, favor IBM, GOOG, or MSFT over pure-play quantum equities for 6-18 month quantum optionality; their downside is not dependent on external capital markets, while any credible quantum commercialization remains upside optionality.